3ut3
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==A novel PAI-I inhibitor and its structural mechanism== | ==A novel PAI-I inhibitor and its structural mechanism== | ||
- | <StructureSection load='3ut3' size='340' side='right' caption='[[3ut3]], [[Resolution|resolution]] 2.42Å' scene=''> | + | <StructureSection load='3ut3' size='340' side='right'caption='[[3ut3]], [[Resolution|resolution]] 2.42Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[3ut3]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3ut3]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3UT3 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3UT3 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EMJ:2,5-DIHYDROXY-3-UNDECYLCYCLOHEXA-2,5-DIENE-1,4-DIONE'>EMJ</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EMJ:2,5-DIHYDROXY-3-UNDECYLCYCLOHEXA-2,5-DIENE-1,4-DIONE'>EMJ</scene></td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">SERPINE1, PAI1, PLANH1 ([ | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">SERPINE1, PAI1, PLANH1 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ut3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ut3 OCA], [https://pdbe.org/3ut3 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ut3 RCSB], [https://www.ebi.ac.uk/pdbsum/3ut3 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ut3 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/PAI1_HUMAN PAI1_HUMAN]] Defects in SERPINE1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1D) [MIM:[https://omim.org/entry/613329 613329]]. It is a hematologic disorder characterized by increased bleeding after trauma, injury, or surgery. Affected females have menorrhagia. The bleeding defect is due to increased fibrinolysis of fibrin blood clots due to deficiency of plasminogen activator inhibitor-1, which inhibits tissue and urinary activators of plasminogen.<ref>PMID:9207454</ref> Note=High concentrations of SERPINE1 seem to contribute to the development of venous but not arterial occlusions. |
== Function == | == Function == | ||
- | [[ | + | [[https://www.uniprot.org/uniprot/PAI1_HUMAN PAI1_HUMAN]] Serine protease inhibitor. This inhibitor acts as 'bait' for tissue plasminogen activator, urokinase, protein C and matriptase-3/TMPRSS7. Its rapid interaction with PLAT may function as a major control point in the regulation of fibrinolysis.<ref>PMID:15853774</ref> |
==See Also== | ==See Also== | ||
Line 20: | Line 20: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Andreasen, P A]] | [[Category: Andreasen, P A]] | ||
[[Category: Hong, Z B]] | [[Category: Hong, Z B]] |
Revision as of 08:04, 20 July 2022
A novel PAI-I inhibitor and its structural mechanism
|
Categories: Human | Large Structures | Andreasen, P A | Hong, Z B | Hu, L H | Huang, M D | Lin, Z H | Shi, X L | Hydrolase inhibitor | Serpin